Anika Therapeutics
ANIK
ANIK
120 hedge funds and large institutions have $376M invested in Anika Therapeutics in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 46 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 125 → 120 (-5)
15% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 46
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
Holders
120
Holding in Top 10
1
Calls
$2.12M
Puts
$29K
Top Buyers
| 1 | +$3.55M | |
| 2 | +$3.43M | |
| 3 | +$1.96M | |
| 4 |
Morgan Stanley
New York
|
+$1.96M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.48M |
Top Sellers
| 1 | -$4.15M | |
| 2 | -$3.71M | |
| 3 | -$3.5M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$2.48M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.08M |